10/6/2025

Paricalcitol Capsules

Products Affected - Description

- Paricalcitol oral capsule, Bionpharma, 1 mcg bottle, 30 count, NDC 69452-0145-13
- Paricalcitol oral capsule, Bionpharma, 2 mcg bottle, 30 count, NDC 69452-0146-13
- Paricalcitol oral capsule, Time-Cap Labs, 1 mcg bottle, 30 count, NDC 49483-0687-03
- Paricalcitol oral capsule, Time-Cap Labs, 4 mcg bottle, 30 count, NDC 49483-0689-03
- Paricalcitol oral capsule, Time-Cap Labs, 2 mcg bottle, 30 count, NDC 49483-0688-03

Reason for the Shortage

- Bionpharma did not provide a reason for the shortage.
- Time-Cap Labs did not provide a reason for the shortage.

Available Products

- Zemplar oral capsule, AbbVie, 2 mcg bottle, 30 count, NDC 00074-9037-30
- Zemplar oral capsule, AbbVie, 1 mcg bottle, 30 count, NDC 00074-9036-30

Estimated Resupply Dates

- Bionpharma has paricalcitol capsules on allocation.
- Time-Cap Labs has paricalcitol capsules on backorder and the company cannot estimate a release date.

Updated

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.